Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Plaque Psoriasis”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04571567
What this trial is testing

Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Saakshi Khattri 20
Testing effectiveness (Phase 2)Study completedNCT04999839
What this trial is testing

Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Takeda 259
Testing effectiveness (Phase 2)Study completedNCT04718896
What this trial is testing

Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
UCB Biopharma SRL 41
Not applicableWithdrawnNCT01758705
What this trial is testing

Post Marketing Observational Study on Venezuelan Patients With Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
AbbVie (prior sponsor, Abbott)
Testing effectiveness (Phase 2)Study completedNCT05003531
What this trial is testing

Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Innovent Biologics (Suzhou) Co. Ltd. 250
Large-scale testing (Phase 3)Study completedNCT02474069
What this trial is testing

Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 772
Post-approval studies (Phase 4)Study completedNCT02186665
What this trial is testing

Plaque Psoriasis Study in Pediatric Subjects

Who this might be right for
Plaque Psoriasis
Galderma R&D 19
Large-scale testing (Phase 3)Study completedNCT00115076
What this trial is testing

Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Rockefeller University 31
Large-scale testing (Phase 3)Study completedNCT00235820
What this trial is testing

Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 271
Large-scale testing (Phase 3)Active Not RecruitingNCT06640517
What this trial is testing

Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in Children With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Biocad 140
Not applicableStudy completedNCT02576197
What this trial is testing

Intervention Study to Evaluate a Probiotic in Mild to Moderate Psoriasis Patients

Who this might be right for
Psoriasis
Biopolis S.L. 98
Post-approval studies (Phase 4)Study completedNCT00967538
What this trial is testing

Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments

Who this might be right for
Psoriasis
Innovaderm Research Inc. 89
Post-approval studies (Phase 4)Study completedNCT06032858
What this trial is testing

Efficacy and Safety of Apremilast in Psoriasis

Who this might be right for
Psoriasis
Ghurki Trust and Teaching Hospital 30
Not applicableStudy completedNCT01555606
What this trial is testing

An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Janssen Biotech, Inc. 108
Large-scale testing (Phase 3)Study completedNCT02694523
What this trial is testing

BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 684
Large-scale testing (Phase 3)Study completedNCT00570986
What this trial is testing

A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 1,465
Large-scale testing (Phase 3)Study completedNCT01646073
What this trial is testing

Safety and Efficacy Study of Adalimumab in the Treatment of Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 425
Large-scale testing (Phase 3)Study completedNCT03668613
What this trial is testing

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 84
Large-scale testing (Phase 3)UnknownNCT02701205
What this trial is testing

Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasis
Shanghai Celgen Bio-Pharmaceutical Co.,Ltd 216
Large-scale testing (Phase 3)Study completedNCT03518047
What this trial is testing

Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation

Who this might be right for
Psoriasis
AbbVie 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation